Go to content
Office of Research

News & Events

In the Spotlight

NIH Shared Instrumentation Grant Program (S10)


Grant Program Information

Current Closing Date for Applications: Mar 21, 2013

Expected Number of Awards: 85

Estimated Total Program Funding: $43,000,000

Award Ceiling: $500,000

CFDA Number(s): 93.351 -- Research Infrastructure Programs

Cost Sharing or Matching Requirement: No


Eligible Applicants

Public and State controlled institutions of higher education

Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher


Private institutions of higher education

Others (see text field entitled "Additional Information on Eligibility" for clarification)



The ORIP Shared Instrument Grant (SIG) program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instrumentation or an integrated system that costs at least $100,000. The maximum award is $600,000. Types of instruments supported include, but are not limited to, confocal and electron microscopes, biomedical imagers, mass spectrometers, DNA sequencers, biosensors, cell-sorters, X-ray diffraction systems, and Nuclear Magnetic Resonance (NMR) spectrometers among others.


Additional Information


CPRIT Early Translational Research Awards

CPRIT recently released a new RFA for Early Transitional Research Awards (ETRA).  As stated in the RFA, the Texas A&M Health Science Center is limited to four (4) submissions.  Therefore, all investigators who are interested in submitting for this mechanism must participate in an internal vetting process. Faculty interested in applying for this mechanism are required to receive institutional approval of a letter of intent and an internal pre-proposal in order to be considered for submission of an application to CPRIT. 



Applicants may request a maximum of $1,000,000 in total costs over a period of 1 to 3 years.


RFA Summary:

This Request for Applications (RFA) solicits applications for innovative research projects addressing critically important questions that will significantly advance the treatment of cancer. The objective of this award is to “bridge the gap” between promising new discoveries achieved in the research laboratory and commercial development by funding attainment of a Target Product Profile for the therapeutic, device, or diagnostic assay through activities up to and including preclinical proof-of-principle data that demonstrate applicability to the planned clinical scenario. The work funded under this RFA must be deemed sufficiently robust such that successful completion would result in identification of a “lead” compound, assay, or device that, as a next stage, could be taken into full development in compliance with International Conference on Harmonization (ICH) Guidelines and U.S. regulatory guidance documents and regulations.


Key Dates:


November 5, 2012: RFA and CPRIT online application become available.


November 16, 2012, 12:00 pm: Deadline for letter of intent, including name of the PI, title of internal proposal and 1-3 sentence description of the project.  LOI should be submitted to Amanda Allen at research@tamhsc.edu.


November 20, 2012, 5:00 pm: Deadline to submit an internal proposal to the Office of the Vice President for Research (OVPR) for review by an internal selection committee. 


Applicants must complete a pre-proposal consisting of a 1-3 page summary of the project, budget and PI Biosketch.  Internal applications must be submitted to research@tamhsc.edu with the subject line “CPRIT Pre-Proposal”.


November 30, 2012: OVPR Selection Committee will notify PIs of the results of the HSC competition.


December 14, 2011: Deadline for the full proposal submission to CPRIT.